Engraftment Syndrome
Presentation :
- Spitzer's Criteria: Within 96h of engraftment (neutrophils >500 for 2+ consecutive days), must have: all 3 major criteria OR 2 major + 1 minor criteria
- Major Criteria:
- Temperature of >38.3 °C with no identifiable infectious etiology.- Erythrodermatous rash involving more than 25% of body surface area and not attributable to medication
- Noncardiogenic pulmonary edema, manifested by diffuse pulmonary infiltrates consistent with this diagnosis, and hypoxia.
- Minor Criteria:
- Hepatic dysfunction with either total bilirubin >2 mg/dlor transaminase levels >two times normal
- Renal insufficiency (serum creatinine of >two times baseline)
- Weight gain >2.5% of baseline body weight.
- Transient encephalopathy unexplainable by other causes.
- Major Criteria:
- Maiolino’s criteria: Anytime from 24h prior to engraftment or any time thereafter must have: Noninfectious fever AND one of the following:
- Rash
- Pulmonary infiltrates
- Diarrhea (at least two episodes of liquid BM per day without any microbiological evidence of infection)
Pathophysiology :
- Thought related to the release of pro-inflammatory cytokines during neutrophil recovery after transplantation (hence the time proximity to engraftment)
Diagnostic Testing:
Treatment :
- Supportive care including: antipyretics, O2, topical therapy for rash, and diuretics can resolve ES in ≥20% of patients
- Generally very corticosteroid-responsive. Methylprednisolone at a starting dose of 1 mg/kg/day is usually sufficient
Prognosis:
References:
- https://www.nature.com/articles/s41409-022-01849-6 (particularly table 1)
Created on: Tuesday 11-21-2023